Skip to main content

SOLARA · Solara Active Pharma Sciences Limited

690.60 INR +15.30 (+2.27%) At close · Nov 13
Volume · Nov 13 15.13K Avg daily vol (3M) 26.75K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Investor day
Close690.60 INR Open675.00 INR Day675.00–719.50 INR 52W close425.05–756.60 INR Avg vol 30d17K Last earningsOct 16, 2026 DataJan 2020–Nov 2026

Latest documents

2026
Oct 16
Earnings call
Q2 2027 earnings call

Solara Active Pharma Sciences Limited reported revenue growth of 33% year-on-year, base-business revenue growth of 37% to 327 crores, and EBITDA margin expansion to 18.4% from 11%. It expects to close the ibuprofen strategic review in 12 weeks.

All documents

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 425.05 INR Now 690.60 INR · 80% Range high 756.60 INR
vs 200-day avg +23% vs 50-day avg +2%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XBOM:SOLARA +8.8% +5.8% +25.8% +9.1% +22.6%

Exchange listing

Market
XBOM
Ticker
SOLARA
ISIN
INE624Z01016
Security
Ordinary share
Trading currency
INR

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Recent dividends

Ex-dividend dateAmount per share
2021-08-18 2.7649 INR
2020-11-19 3.6866 INR
2020-07-28 1.8433 INR
2019-08-06 5.00 INR

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q2 2027 2026-10-16 Audio Transcript
    Earnings Call for the Quarter Ended September 30, 2026
  • Earnings call · Q1 2027 2026-07-23 Audio Transcript
    Earnings Call for the Quarter Ended June 30, 2026
  • Earnings call · Q4 2026 2026-05-15 Audio Transcript
    Earnings Call for the Quarter Ended March 31, 2026